Cargando…

Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia

Introduction: Cases of de novo immune thrombocytopenia (ITP), including a fatality following SARS-CoV-2 vaccination in a previously healthy recipient, led to studying its impact in pre-existing ITP. Published reports are limited but suggest that most patients with ITP tolerate the COVID-19 vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Eun-Ju, Beltrami Moreira, Marina, Al-Samkari, Hanny, Cuker, Adam, MacWhirter - DiRaimo, Jennifer, Gernsheimer, Terry B., Kruse, Alexandra, Kessler, Craig M., Kruse, Caroline, Leavitt, Andrew D, Lee, Alfred Ian, Liebman, Howard A., Newland, Adrian C., Ray, Ashley E., Tarantino, Michael D, Thachil, Jecko, Kuter, David J., Cines, Douglas B., Bussel, James B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2021
Materias:	311.Disorders of Platelet Number or Function: Clinical and Epidemiological
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701617/ http://dx.doi.org/10.1182/blood-2021-152918

Ejemplares similares

COVID-19 Vaccination in Adults with Immune Thrombocytopenia (ITP): Data from the Platelet Disorder Support Association (PDSA) Patient Registry
por: MacWhirter - DiRaimo, Jennifer, et al.
Publicado: (2021)

Do Splenectomized Immune Thrombocytopenia (ITP) Patients Have Increased Risks for Platelet Decreases Following COVID-19 Vaccination?
por: MacWhirter - DiRaimo, Jennifer, et al.
Publicado: (2021)

SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
por: Lee, Eun-Ju, et al.
Publicado: (2022)

Immune Thrombocytopenia Associated with COVID-19 - Case Series
por: Fatkhullin, Ramil, et al.
Publicado: (2020)

Thrombocytopenia Associated with Increase in Disease Severity and Mortality in COVID-19 Patients
por: Banwait, Ranjit, et al.
Publicado: (2020)

Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients
por: Gavriilaki, Eleni, et al.
Publicado: (2020)

Heparin Induced Thrombocytopenia in Patients with COVID-19
por: Warrior, Surbhi, et al.
Publicado: (2020)

Does Thrombocytopenia Truly Correlate with COVID-19 Severity?
por: Hana, Caroline, et al.
Publicado: (2020)

Spontaneous Heparin-Induced Thrombocytopenia and COVID-19 Infection
por: Amara, Suneetha
Publicado: (2021)

Identification of Complement-Related Missense Variants in Pediatric Patients with Acute and Post COVID-19 Syndromes
por: Gavriilaki, Eleni, et al.
Publicado: (2021)

Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination
por: Francisco, Michael T., et al.
Publicado: (2021)

SOCS1 Haploinsufficiency Presenting As Incidental Refractory Thrombocytopenia in a Pediatric Patient with Inflammatory Symptoms and History of Sars Cov-2 Infection
por: Lapinski, Jillian, et al.
Publicado: (2021)

The Effect of COVID-19 Vaccine in Patients with Immune Thrombocytopenia
por: Visser, Chantal, et al.
Publicado: (2021)

Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination
por: Schieppati, Francesca, et al.
Publicado: (2021)

Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study
por: Al‐Samkari, Hanny, et al.
Publicado: (2022)

Does IVIG Use Reduce the Risk of Contracting Sars-Cov-2 in Patients with Immune Thrombocytopenia: Data from the Platelet Disorder Support Association (PDSA) Patient Registry
por: MacWhirter - DiRaimo, Jennifer, et al.
Publicado: (2022)

COVID-19 Vaccination in Children and Young Adults with Pre-Existing Immune Thrombocytopenia (ITP): Preliminary Data from the Platelet Disorder Support Association (PDSA) Patient Registry
por: MacWhirter - DiRaimo, Jennifer, et al.
Publicado: (2022)

When Third Time's a Charm: Successful Outcome after Third Orthotopic Heart Transplantation
por: Patlolla, Srikant, et al.
Publicado: (2020)

P1637: RISKS FOR A PLATELET COUNT DROP: COVID-19 & ITP DATA FROM THE PLATELET DISORDER SUPPORT ASSOCIATION (PDSA) PATIENT REGISTRY
por: DiRaimo, J., et al.
Publicado: (2022)

Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia
por: Al-Samkari, Hanny, et al.
Publicado: (2023)

IMPACTO DA PANDEMIA DE SARS-COV-2 NA INCIDÊNCIA DE HANSENÍASE NO BRASIL: COMPARAÇÃO COM OS ÚLTIMOS 5 ANOS
por: Pschichholz, Laura
Publicado: (2022)

Facteurs prédictifs d’une poussée de psoriasis après une infection par le SARS-CoV-2 chez l’enfant
por: Mahé, E., et al.
Publicado: (2022)

Functional bowel symptoms, fibromyalgia and fatigue: A food-induced triad?
por: Berstad, Arnold, et al.
Publicado: (2012)

Diagnostic pitfalls in functional neurological disorders
por: Pimentel, Lucio Huebra, et al.
Publicado: (2022)

Comparative analysis of marketed factor VIII products: reply
por: Reipert, B. M., et al.
Publicado: (2018)

Protein kinase Cε and protein kinase Cθ double-deficient mice have a bleeding diathesis
por: UNSWORTH, A J, et al.
Publicado: (2012)

The platelet-surface thiol isomerase enzyme ERp57 modulates platelet function
por: Holbrook, L-M, et al.
Publicado: (2012)

Dimeric FcγR ectodomains detect pathogenic anti‐platelet factor 4–heparin antibodies in heparin‐induced thromobocytopenia
por: Wines, B. D., et al.
Publicado: (2018)

A humanized monoclonal antibody that inhibits platelet‐surface ERp72 reveals a role for ERp72 in thrombosis
por: Holbrook, L.‐M., et al.
Publicado: (2018)

Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies
por: Kuter, David J., et al.
Publicado: (2019)

Fostamatinib is an effective second‐line therapy in patients with immune thrombocytopenia
por: Boccia, Ralph, et al.
Publicado: (2020)

Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia
por: Broome, Catherine M., et al.
Publicado: (2022)

Mean platelet size related to glycoprotein-specific autoantibodies and platelet-associated IgG
por: JAVELA, K, et al.
Publicado: (2007)

Differential roles for the adapters Gads and LAT in platelet activation by GPVI and CLEC-2
por: HUGHES, C E, et al.
Publicado: (2008)

Non-genomic effects of PPARγ ligands: inhibition of GPVI-stimulated platelet activation
por: Moraes, L A, et al.
Publicado: (2010)

Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells
por: Moraes, L A, et al.
Publicado: (2010)

CLEC‐2‐dependent activation of mouse platelets is weakly inhibited by cAMP but not by cGMP
por: Borgognone, A., et al.
Publicado: (2014)

Manipulating megakaryocytes to manufacture platelets ex vivo
por: Karagiannis, P, et al.
Publicado: (2015)

Akt and mitogen‐activated protein kinase enhance C‐type lectin‐like receptor 2‐mediated platelet activation by inhibition of glycogen synthase kinase 3α/β
por: Moroi, A. J., et al.
Publicado: (2015)

Modified platelet deposition on matrix metalloproteinase 13 digested collagen I
por: Howes, J.‐M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i50ug181gmueic67dkahsnh0lo